Results 291 to 300 of about 279,445 (313)

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2022
Luca Richeldi, Arata Azuma, Vincent Cottin   +2 more
exaly  

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2022
Ganesh Raghu, Martine Remy-Jardin, Luca Richeldi   +2 more
exaly  

Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis

New England Journal of Medicine, 2012
Ganesh Raghu, Kevin J Anstrom, Joseph A Lasky   +2 more
exaly  

PULMONARY FIBROSIS IN SCLERODERMA

British Journal of Dermatology, 1949
J E M, WIGLEY, V, EDMUNDS, R, BRADLEY
openaire   +2 more sources

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2011
Luca Richeldi, Ulrich Costabel, Moises Selman   +2 more
exaly  

Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2014
Fernando J Martinez, João A de Andrade, Kevin J Anstrom   +2 more
exaly  

A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis

New England Journal of Medicine, 2011
Max A Seibold, Mark P Steele, James E Loyd   +2 more
exaly  

Reversal of TGFβ1-Driven Profibrotic State in Patients with Pulmonary Fibrosis

New England Journal of Medicine, 2020
Harold A Chapman, Genevieve Montas, Paul J Wolters   +2 more
exaly  

A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2010
David A Zisman, Kevin J Anstrom, Kevin R Flaherty   +2 more
exaly  

A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2004
Ganesh Raghu, Kevin K Brown, Williamson Z Bradford   +2 more
exaly